SCHEMBL24745178

SCHEMBL24745178

O=C1c2ccccc2C(O)N1CCOCCOCCCO

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ HPGD P15428 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ PKM P14618 1/20 0.46
▸ TSHR P16473 2/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TOP1 P11387 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19231927 0.92 L3MBTL1 (0.53) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL23720475 0.92 L3MBTL1 (0.53) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL18950714 0.85 L3MBTL1 (0.52) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL18677687 0.85 L3MBTL1 (0.52) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL25985038 0.85 L3MBTL1 (0.49) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL23585046 0.84 L3MBTL1 (0.59) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL18970374 0.84 L3MBTL1 (0.53) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL20216016 0.83 L3MBTL1 (0.58) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL16392966 0.82 L3MBTL1 (0.57) L3MBTL1HPGDLMNAALDH1A1PKM
SCHEMBL20924684 0.81 L3MBTL1 (0.62) L3MBTL1HPGDLMNAALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
Send feedback